{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:06:58Z","timestamp":1788538018586,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Bisphosponate use may decrease the risk of fracture in patients receiving kidney transplant.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Identifying those at risk of fracture after kidney transplant is critical.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Kidney transplant recipients are at higher risk of fractures compared with the general population. The use of bisphosphonates has been shown to increase bone mineral density after transplantation but has not been shown to lower fracture rates. In this study, we aim to determine whether exposure to bisphosphonates is associated with lower incidence of nonvertebral fractures after kidney transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective review for all Southern California Kaiser Permanente kidney transplant recipients with osteoporosis transplanted between 2000 and 2019. Baseline variables were collected. Those prescribed an oral bisphosphonate were compared with those who were not. The primary outcome was nonvertebral fracture. Chi-square test was used to evaluate categorical variables and Wilcoxon rank-sum test for continuous variables. Propensity scores were generated to balance covariates in the bisphosphonate and nonbisphosphonate groups. Cause-specific hazard and subdistribution (Fine\u2013Gray) methods were performed for competing risk analysis. Death-censored graft survival was evaluated as a secondary outcome using standard Cox regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were 489 patients included in the study, 203 of which were in the bisphosphonate group. The cause-specific hazard model suggested a 64% lower risk of nonvertebral fracture in the bisphosphonate group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.02). The Fine\u2013Gray hazard model treating death as a competing risk did not show lower relative incidence of nonvertebral fracture. Bisphosphonate treatment was associated with lower death-censored graft failure (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Bisphosphonate use after kidney transplantation may be associated with a lower risk of nonvertebral fracture after transplant. Bisphosphonate use in this study was also associated with lower death-censored graft failure. Caution is advised when interpreting these results given the retrospective nature of the study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.0000000591","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:00:26Z","timestamp":1730808026000},"page":"267-276","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Bisphosphonate Use after Kidney Transplantation Is Associated with Lower Fracture Risk"],"prefix":"10.2215","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6847-6951","authenticated-orcid":false,"given":"Joseph M.","family":"Kahwaji","sequence":"first","affiliation":[{"name":"Department of Nephrology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0972-0720","authenticated-orcid":false,"given":"Su-Jau","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Foundation Hospitals, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9456-8243","authenticated-orcid":false,"given":"John J.","family":"Sim","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Young","family":"Parke","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland L.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"issue":"1","key":"B1-20260423","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/TP.0000000000000808","article-title":"Fracture incidence in adult kidney transplant recipients","volume":"100","author":"Naylor","year":"2016","journal-title":"Transplantation."},{"issue":"5","key":"B2-20260423","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00198-018-4383-2","article-title":"Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort","volume":"29","author":"Segaud","year":"2018","journal-title":"Osteoporos Int."},{"issue":"12","key":"B3-20260423","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1097\/TP.0b013e3181a6bbda","article-title":"Risk of fractures after renal transplantation in the United States","volume":"87","author":"Nikkel","year":"2009","journal-title":"Transplantation."},{"key":"B4-20260423","doi-asserted-by":"crossref","first-page":"115554","DOI":"10.1016\/j.bone.2020.115554","article-title":"Fractures after kidney transplantation: incidence, predictors, and association with mortality","volume":"140","author":"Iseri","year":"2020","journal-title":"Bone."},{"issue":"1","key":"B5-20260423","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.2013.279","article-title":"Response to High rates of death and hospitalization follow bone fracture among hemodialysis patients","volume":"85","author":"Tentori","year":"2013","journal-title":"Kidney Int."},{"issue":"8","key":"B6-20260423","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/jgs.15962","article-title":"Fractures and subsequent graft loss and mortality among older kidney transplant recipients","volume":"67","author":"Salter","year":"2019","journal-title":"J Am Geriatr Soc."},{"issue":"4","key":"B7-20260423","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/ajt.12652","article-title":"Temporal trends in the incidence, treatment, and outcomes of hip fracture after first kidney transplantation in the United States","volume":"14","author":"Sukumaran","year":"2014","journal-title":"Am J Transplant."},{"issue":"5","key":"B8-20260423","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.nefro.2017.12.006","article-title":"Osteoporosis, bone mineral density and CKD-MBD complex (I): diagnostic considerations","volume":"38","author":"Bover","year":"2018","journal-title":"Nefrologia."},{"issue":"1","key":"B10-20260423","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2215\/CJN.02550508","article-title":"Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue","volume":"4","author":"Toussaint","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"issue":"8","key":"B11-20260423","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.transproceed.2013.08.066","article-title":"Impact of Vitamin D, bisphosphonate, and combination therapy on bone mineral density in kidney transplant patients","volume":"45","author":"Jeon","year":"2013","journal-title":"Transplant Proc."},{"issue":"6","key":"B12-20260423","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/ajt.13692","article-title":"Effect of twice yearly denosumab on prevention of bone mineral density loss in de novo kidney transplant recipients: a randomized controlled trial","volume":"16","author":"Bonani","year":"2016","journal-title":"Am J Transplant."},{"issue":"8","key":"B13-20260423","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/ndt\/gfl104","article-title":"Effects of bisphosphonates on bone loss in the first year after renal transplantation \u2013 a meta-analysis of randomized controlled trials","volume":"21","author":"Mitterbauer","year":"2006","journal-title":"Nephrol Dial Transplant."},{"issue":"9","key":"B14-20260423","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/ctr.12792","article-title":"Outcomes of bisphosphonate therapy in kidney transplant recipients: a systematic review and meta-analysis","volume":"30","author":"Toth-Manikowski","year":"2016","journal-title":"Clin Transplant."},{"key":"B15-20260423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2054358119858014","article-title":"Effect of bisphosphonate on bone health in adult renal transplant patients: beyond the first year posttransplant-a systematic meta-analysis","volume":"6","author":"Lip","year":"2019","journal-title":"Can J Kidney Health Dis."},{"issue":"1","key":"B16-20260423","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00198-003-1490-4","article-title":"Mortality after osteoporotic fractures","volume":"15","author":"Johnell","year":"2004","journal-title":"Osteoporos Int."},{"issue":"1","key":"B17-20260423","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int."},{"issue":"2","key":"B18-20260423","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/TP.0b013e318176b40f","article-title":"Bisphosphonates and bone fractures in long-term kidney transplant recipients","volume":"86","author":"Conley","year":"2008","journal-title":"Transplantation."},{"issue":"10","key":"B19-20260423","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1097\/01.ASN.0000087092.53894.80","article-title":"Prevention of bone loss in renal transplant recipients a prospective, randomized trial of intravenous pamidronate","volume":"14","author":"Coco","year":"2003","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B20-20260423","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2215\/CJN.11371015","article-title":"Bone disease after kidney transplantation","volume":"11","author":"Bouquegneau","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"issue":"6","key":"B21-20260423","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/ajt.12738","article-title":"Vitamin D in renal transplantation \u2013 from biological mechanisms to clinical benefits","volume":"14","author":"McGregor","year":"2014","journal-title":"Am J Transplant."},{"issue":"4","key":"B22-20260423","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5500\/wjt.v5.i4.231","article-title":"Mineral and bone disorder after kidney transplantation","volume":"5","author":"Taweesedt","year":"2015","journal-title":"World J Transplant."},{"issue":"4","key":"B23-20260423","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ndt\/gfaa371","article-title":"Effects of bisphosphonates on long-term kidney transplantation outcomes","volume":"36","author":"Song","year":"2021","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B24-20260423","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/TP.0000000000001452","article-title":"Interleukin-6, a cytokine critical to mediation of inflammation, autoimmunity and allograft rejection therapeutic implications of IL-6 receptor blockade","volume":"101","author":"Jordan","year":"2017","journal-title":"Transplantation."},{"issue":"1","key":"B25-20260423","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/030097498441155","article-title":"Bisphosphonates inhibit IL-6 production by human osteoblast-like cells","volume":"27","author":"Giuliani","year":"1998","journal-title":"Scand J Rheumatol."},{"issue":"2-3","key":"B26-20260423","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10787-015-0233-4","article-title":"Effect of bisphosphonates treatment on cytokine imbalance between TH17 and Treg in osteoporosis","volume":"23","author":"Talaat","year":"2015","journal-title":"Inflammopharmacology."},{"issue":"1","key":"B27-20260423","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jbspin.2006.06.005","article-title":"Extra-skeletal effects of bisphosphonates","volume":"74","author":"Corrado","year":"2007","journal-title":"Joint Bone Spine."},{"issue":"7","key":"B28-20260423","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1681\/ASN.V1271530","article-title":"Effect of ibandronate on bone loss and renal function after kidney transplantation","volume":"12","author":"Grotz","year":"2001","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B29-20260423","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","article-title":"Bone mineral density, bone turnover markers, and\u00a0incident fractures in de novo kidney transplant\u00a0recipients","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int."},{"issue":"8","key":"B30-20260423","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1016\/j.transproceed.2019.03.071","article-title":"Pretransplant osteoporosis and osteopenia are risk factors for fractures after kidney transplantation","volume":"51","author":"Lee","year":"2019","journal-title":"Transplant Proc."},{"issue":"6","key":"B31-20260423","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2215\/CJN.09950818","article-title":"Changes in bone histomorphometry after kidney transplantation","volume":"14","author":"Keronen","year":"2019","journal-title":"Clin J Am Soc Nephrol."},{"issue":"11","key":"B32-20260423","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/ndt\/gfab239","article-title":"Patterns of renal osteodystrophy 1 year after kidney transplantation","volume":"36","author":"J\u00f8rgensen","year":"2021","journal-title":"Nephrol Dial Transplant."},{"key":"B33-20260423","doi-asserted-by":"crossref","first-page":"269613","DOI":"10.1155\/2014\/269613","article-title":"Alendronate as an effective treatment for bone loss and vascular calcification in kidney transplant recipients","volume":"2014","author":"Okamoto","year":"2014","journal-title":"J Transplant."},{"issue":"11","key":"B34-20260423","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1359\/jbmr.2001.16.11.2111","article-title":"Alendronate prevents further bone loss in renal transplant recipients","volume":"16","author":"Giannini","year":"2001","journal-title":"J Bone Miner Res."},{"issue":"1","key":"B35-20260423","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1034\/j.1600-6143.2002.020111.x","article-title":"Treatment of osteoporosis and osteopenia in long-term renal transplant patients with alendronate","volume":"2","author":"Cruz","year":"2002","journal-title":"Am J Transplant."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:40:16Z","timestamp":1786369216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000000591","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"2024-03-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}